|
5.1 Primary
malignant disease: lung cancer vs. gastrointestinal cancer vs.
other (specify).
5.2
Severity of weight loss (excluding perioperative weight loss)
in preceding 2 months: <4.6 kg (<10 lbs.) vs. ³4.6
kg (³10
lbs.).
5.3
Planned concurrent chemotherapy at the time of study entry: none
vs. with cisplatin vs. noncisplatin chemotherapy.
5.4 Sex: male
vs. female.
5.5 ECOG PS:
0-1 vs. 2.
5.6
Physician estimate of survival: <4 months vs. 4 - 6 months vs.
>6 months.
5.7
Planned concurrent radiation therapy: yes vs. no.
5.8 Patient
age: <50 years vs. ³50
years.
|